Impact of induced acute arterial hypertension on postoperative nalbuphine analgesic requirement during laparoscopic ovarian cystectomy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201508001247179

Enrollment

Registered

2015-08-24

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Surgery Postoperative analgesia Anaesthesia

Interventions

Hypertension group: the systolic arterial blood pressure will be maintained at 20%-30% above baselin

Control group: the systolic arterial blood pressure will be maintained at 20%-30% below baseline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 20-50 ASA I-II Elective laparoscopic ovarian cystectomy. Under general anesthesia 90 minutes procedures

Exclusion criteria

Exclusion criteria: history of chronic arterial hypertension, a baseline arterial pressure more than 139/89 mm Hg after admission to the hospital, chronic pain, drug abuse, any known cerebrovascular disease, obesity (body mass index > 35), use of any analgesic drugs and/or drugs acting on the central nervous system, known pregnancy, or known adverse effects to the study drugs.

Design outcomes

Primary

Measure	Time frame
VAS score	—

Secondary

Measure	Time frame
hemodynamic, Total dose of analgesics, PONV	—

Countries

Egypt

Contacts

Public ContactNASR MAHMOUD

MD degree, lecturer of anesthesia, pain and surgical ICU

seif.nasr@yahoo.com+201005223734

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026